APO Research
Talk to an analyst

APO RESEARCH · REPORT

Saliva Drug and Alcohol Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Saliva Drug and Alcohol Testing Market Analysis and Forecast 2026-2032

1 May 2026251 pages

Choose your research edition.

Industry ResearchSaliva Drug and Alcohol Testing Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Saliva Drug and Alcohol Testing Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Saliva Drug and Alcohol Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Saliva Drug and Alcohol Testing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Saliva Drug and Alcohol Testing Market Analysis and Forecast 2026-2032251 pages · $4,950 USD

Market perspective

The global Saliva Drug and Alcohol Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Saliva Drug and Alcohol Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Saliva Drug and Alcohol Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Saliva Drug and Alcohol Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Saliva Drug and Alcohol Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Saliva Drug and Alcohol Testing include Abbott, OraSure Technologies, Premier Biotech, Alcolizer, CareHealth America, AlphaBiolabs, AlcoDigital, VeriCheck and Azova, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Saliva Drug and Alcohol Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Saliva Drug and Alcohol Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Saliva Drug and Alcohol Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Saliva Drug and Alcohol Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Saliva Drug and Alcohol Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Saliva Drug and Alcohol Testing revenue, projected growth trends, production technology, application and end-user industry.

Saliva Drug and Alcohol Testing Segment by Company

Abbott

OraSure Technologies

Premier Biotech

Alcolizer

CareHealth America

AlphaBiolabs

AlcoDigital

VeriCheck

Azova

Draeger

Securetec Detektions-Systeme

Quest Diagnostics

Oranoxis

Salimetrics

Neogen Corporation

UCP Biosciences

Lin-Zhi International

MEDACX

AccuBioTech

Wondfo Biotech

Assure Tech

Express Medicals

Crystal Health

KINNECT

AusHealth

Dorevitch Pathology

Labcorp

Eurofins

Concentra

Bellin Health

Randox

MediNat

Clinical Labs

MHE

Awanui Labs

David Barber Occupational Health

SYNLAB

Test Smartly Labs

Cansford Laboratories

Medigold Health

PAM Group

Drugwise

Safework Health

Humanomics

CannAmm

Micro-Distributing

Saliva Drug and Alcohol Testing Segment by Type

On-Site Screening Products

Lab Testing

Saliva Drug and Alcohol Testing Segment by Application

Criminal Justice Testing

Workplace Testing

Rehabilitation Therapy

Others

Saliva Drug and Alcohol Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saliva Drug and Alcohol Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saliva Drug and Alcohol Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saliva Drug and Alcohol Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Saliva Drug and Alcohol Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Saliva Drug and Alcohol Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Saliva Drug and Alcohol Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Saliva Drug and Alcohol Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-Site Screening Products Major Player Table 3. Lab Testing Major Player Table 4. Global Saliva Drug and Alcohol Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Criminal Justice Testing Major Player Table 6. Workplace Testing Major Player Table 7. Rehabilitation Therapy Major Player Table 8. Others Major Player Table 9. Saliva Drug and Alcohol Testing Industry Trends Table 10. Saliva Drug and Alcohol Testing Industry Drivers Table 11. Saliva Drug and Alcohol Testing Industry Opportunities and Challenges Table 12. Saliva Drug and Alcohol Testing Industry Restraints Table 13. Global Saliva Drug and Alcohol Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Saliva Drug and Alcohol Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Saliva Drug and Alcohol Testing Market Share by Region (2021-2026) Table 16. Global Saliva Drug and Alcohol Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Saliva Drug and Alcohol Testing Market Share by Region (2027-2032) Table 18. Global Saliva Drug and Alcohol Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Saliva Drug and Alcohol Testing Revenue Market Share by Players (2021-2026) Table 20. Global Saliva Drug and Alcohol Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Saliva Drug and Alcohol Testing Key Players Headquarters & Area Served Table 22. Global Saliva Drug and Alcohol Testing Players, Product Type & Application Table 23. Global Saliva Drug and Alcohol Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Saliva Drug and Alcohol Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Saliva Drug and Alcohol Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Saliva Drug and Alcohol Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Saliva Drug and Alcohol Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Saliva Drug and Alcohol Testing Revenue Market Share by Type (2021-2026) Table 30. Global Saliva Drug and Alcohol Testing Revenue Market Share by Type (2027-2032) Table 31. Global Saliva Drug and Alcohol Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Saliva Drug and Alcohol Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Saliva Drug and Alcohol Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Saliva Drug and Alcohol Testing Revenue Market Share by Application (2021-2026) Table 35. Global Saliva Drug and Alcohol Testing Revenue Market Share by Application (2027-2032) Table 36. Abbott Company Information Table 37. Abbott Business Overview Table 38. Abbott Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Abbott Saliva Drug and Alcohol Testing Product Portfolio Table 40. Abbott Recent Development Table 41. OraSure Technologies Company Information Table 42. OraSure Technologies Business Overview Table 43. OraSure Technologies Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. OraSure Technologies Saliva Drug and Alcohol Testing Product Portfolio Table 45. OraSure Technologies Recent Development Table 46. Premier Biotech Company Information Table 47. Premier Biotech Business Overview Table 48. Premier Biotech Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Premier Biotech Saliva Drug and Alcohol Testing Product Portfolio Table 50. Premier Biotech Recent Development Table 51. Alcolizer Company Information Table 52. Alcolizer Business Overview Table 53. Alcolizer Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Alcolizer Saliva Drug and Alcohol Testing Product Portfolio Table 55. Alcolizer Recent Development Table 56. CareHealth America Company Information Table 57. CareHealth America Business Overview Table 58. CareHealth America Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. CareHealth America Saliva Drug and Alcohol Testing Product Portfolio Table 60. CareHealth America Recent Development Table 61. AlphaBiolabs Company Information Table 62. AlphaBiolabs Business Overview Table 63. AlphaBiolabs Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. AlphaBiolabs Saliva Drug and Alcohol Testing Product Portfolio Table 65. AlphaBiolabs Recent Development Table 66. AlcoDigital Company Information Table 67. AlcoDigital Business Overview Table 68. AlcoDigital Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. AlcoDigital Saliva Drug and Alcohol Testing Product Portfolio Table 70. AlcoDigital Recent Development Table 71. VeriCheck Company Information Table 72. VeriCheck Business Overview Table 73. VeriCheck Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. VeriCheck Saliva Drug and Alcohol Testing Product Portfolio Table 75. VeriCheck Recent Development Table 76. Azova Company Information Table 77. Azova Business Overview Table 78. Azova Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Azova Saliva Drug and Alcohol Testing Product Portfolio Table 80. Azova Recent Development Table 81. Draeger Company Information Table 82. Draeger Business Overview Table 83. Draeger Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Draeger Saliva Drug and Alcohol Testing Product Portfolio Table 85. Draeger Recent Development Table 86. Securetec Detektions-Systeme Company Information Table 87. Securetec Detektions-Systeme Business Overview Table 88. Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Product Portfolio Table 90. Securetec Detektions-Systeme Recent Development Table 91. Quest Diagnostics Company Information Table 92. Quest Diagnostics Business Overview Table 93. Quest Diagnostics Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Quest Diagnostics Saliva Drug and Alcohol Testing Product Portfolio Table 95. Quest Diagnostics Recent Development Table 96. Oranoxis Company Information Table 97. Oranoxis Business Overview Table 98. Oranoxis Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Oranoxis Saliva Drug and Alcohol Testing Product Portfolio Table 100. Oranoxis Recent Development Table 101. Salimetrics Company Information Table 102. Salimetrics Business Overview Table 103. Salimetrics Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Salimetrics Saliva Drug and Alcohol Testing Product Portfolio Table 105. Salimetrics Recent Development Table 106. Neogen Corporation Company Information Table 107. Neogen Corporation Business Overview Table 108. Neogen Corporation Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Neogen Corporation Saliva Drug and Alcohol Testing Product Portfolio Table 110. Neogen Corporation Recent Development Table 111. UCP Biosciences Company Information Table 112. UCP Biosciences Business Overview Table 113. UCP Biosciences Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. UCP Biosciences Saliva Drug and Alcohol Testing Product Portfolio Table 115. UCP Biosciences Recent Development Table 116. Lin-Zhi International Company Information Table 117. Lin-Zhi International Business Overview Table 118. Lin-Zhi International Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Lin-Zhi International Saliva Drug and Alcohol Testing Product Portfolio Table 120. Lin-Zhi International Recent Development Table 121. MEDACX Company Information Table 122. MEDACX Business Overview Table 123. MEDACX Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. MEDACX Saliva Drug and Alcohol Testing Product Portfolio Table 125. MEDACX Recent Development Table 126. AccuBioTech Company Information Table 127. AccuBioTech Business Overview Table 128. AccuBioTech Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. AccuBioTech Saliva Drug and Alcohol Testing Product Portfolio Table 130. AccuBioTech Recent Development Table 131. Wondfo Biotech Company Information Table 132. Wondfo Biotech Business Overview Table 133. Wondfo Biotech Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Wondfo Biotech Saliva Drug and Alcohol Testing Product Portfolio Table 135. Wondfo Biotech Recent Development Table 136. Assure Tech Company Information Table 137. Assure Tech Business Overview Table 138. Assure Tech Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Assure Tech Saliva Drug and Alcohol Testing Product Portfolio Table 140. Assure Tech Recent Development Table 141. Express Medicals Company Information Table 142. Express Medicals Business Overview Table 143. Express Medicals Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Express Medicals Saliva Drug and Alcohol Testing Product Portfolio Table 145. Express Medicals Recent Development Table 146. Crystal Health Company Information Table 147. Crystal Health Business Overview Table 148. Crystal Health Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Crystal Health Saliva Drug and Alcohol Testing Product Portfolio Table 150. Crystal Health Recent Development Table 151. KINNECT Company Information Table 152. KINNECT Business Overview Table 153. KINNECT Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. KINNECT Saliva Drug and Alcohol Testing Product Portfolio Table 155. KINNECT Recent Development Table 156. AusHealth Company Information Table 157. AusHealth Business Overview Table 158. AusHealth Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. AusHealth Saliva Drug and Alcohol Testing Product Portfolio Table 160. AusHealth Recent Development Table 161. Dorevitch Pathology Company Information Table 162. Dorevitch Pathology Business Overview Table 163. Dorevitch Pathology Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Dorevitch Pathology Saliva Drug and Alcohol Testing Product Portfolio Table 165. Dorevitch Pathology Recent Development Table 166. Labcorp Company Information Table 167. Labcorp Business Overview Table 168. Labcorp Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Labcorp Saliva Drug and Alcohol Testing Product Portfolio Table 170. Labcorp Recent Development Table 171. Eurofins Company Information Table 172. Eurofins Business Overview Table 173. Eurofins Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Eurofins Saliva Drug and Alcohol Testing Product Portfolio Table 175. Eurofins Recent Development Table 176. Concentra Company Information Table 177. Concentra Business Overview Table 178. Concentra Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Concentra Saliva Drug and Alcohol Testing Product Portfolio Table 180. Concentra Recent Development Table 181. Bellin Health Company Information Table 182. Bellin Health Business Overview Table 183. Bellin Health Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. Bellin Health Saliva Drug and Alcohol Testing Product Portfolio Table 185. Bellin Health Recent Development Table 186. Randox Company Information Table 187. Randox Business Overview Table 188. Randox Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. Randox Saliva Drug and Alcohol Testing Product Portfolio Table 190. Randox Recent Development Table 191. MediNat Company Information Table 192. MediNat Business Overview Table 193. MediNat Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 194. MediNat Saliva Drug and Alcohol Testing Product Portfolio Table 195. MediNat Recent Development Table 196. Clinical Labs Company Information Table 197. Clinical Labs Business Overview Table 198. Clinical Labs Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 199. Clinical Labs Saliva Drug and Alcohol Testing Product Portfolio Table 200. Clinical Labs Recent Development Table 201. MHE Company Information Table 202. MHE Business Overview Table 203. MHE Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 204. MHE Saliva Drug and Alcohol Testing Product Portfolio Table 205. MHE Recent Development Table 206. Awanui Labs Company Information Table 207. Awanui Labs Business Overview Table 208. Awanui Labs Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 209. Awanui Labs Saliva Drug and Alcohol Testing Product Portfolio Table 210. Awanui Labs Recent Development Table 211. David Barber Occupational Health Company Information Table 212. David Barber Occupational Health Business Overview Table 213. David Barber Occupational Health Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 214. David Barber Occupational Health Saliva Drug and Alcohol Testing Product Portfolio Table 215. David Barber Occupational Health Recent Development Table 216. SYNLAB Company Information Table 217. SYNLAB Business Overview Table 218. SYNLAB Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 219. SYNLAB Saliva Drug and Alcohol Testing Product Portfolio Table 220. SYNLAB Recent Development Table 221. Test Smartly Labs Company Information Table 222. Test Smartly Labs Business Overview Table 223. Test Smartly Labs Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 224. Test Smartly Labs Saliva Drug and Alcohol Testing Product Portfolio Table 225. Test Smartly Labs Recent Development Table 226. Cansford Laboratories Company Information Table 227. Cansford Laboratories Business Overview Table 228. Cansford Laboratories Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 229. Cansford Laboratories Saliva Drug and Alcohol Testing Product Portfolio Table 230. Cansford Laboratories Recent Development Table 231. Medigold Health Company Information Table 232. Medigold Health Business Overview Table 233. Medigold Health Saliva Drug and Alcohol Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 234. Medigold Health Saliva Drug and Alcohol Testing Product Portfolio Table 235. Medigold Health Recent Development Table 236. North America Saliva Drug and Alcohol Testing Revenue by Type (2021-2026) & (US$ Million) Table 237. North America Saliva Drug and Alcohol Testing Revenue by Type (2027-2032) & (US$ Million) Table 238. North America Saliva Drug and Alcohol Testing Revenue by Application (2021-2026) & (US$ Million) Table 239. North America Saliva Drug and Alcohol Testing Revenue by Application (2027-2032) & (US$ Million) Table 240. North America Saliva Drug and Alcohol Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. North America Saliva Drug and Alcohol Testing Revenue by Country (2021-2026) & (US$ Million) Table 242. North America Saliva Drug and Alcohol Testing Revenue by Country (US$ Million) & (2027-2032) Table 243. Europe Saliva Drug and Alcohol Testing Revenue by Type (2021-2026) & (US$ Million) Table 244. Europe Saliva Drug and Alcohol Testing Revenue by Type (2027-2032) & (US$ Million) Table 245. Europe Saliva Drug and Alcohol Testing Revenue by Application (2021-2026) & (US$ Million) Table 246. Europe Saliva Drug and Alcohol Testing Revenue by Application (2027-2032) & (US$ Million) Table 247. Europe Saliva Drug and Alcohol Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. Europe Saliva Drug and Alcohol Testing Revenue by Country (2021-2026) & (US$ Million) Table 249. Europe Saliva Drug and Alcohol Testing Revenue by Country (US$ Million) & (2027-2032) Table 250. China Saliva Drug and Alcohol Testing Revenue by Type (2021-2026) & (US$ Million) Table 251. China Saliva Drug and Alcohol Testing Revenue by Type (2027-2032) & (US$ Million) Table 252. China Saliva Drug and Alcohol Testing Revenue by Application (2021-2026) & (US$ Million) Table 253. China Saliva Drug and Alcohol Testing Revenue by Application (2027-2032) & (US$ Million) Table 254. Asia Saliva Drug and Alcohol Testing Revenue by Type (2021-2026) & (US$ Million) Table 255. Asia Saliva Drug and Alcohol Testing Revenue by Type (2027-2032) & (US$ Million) Table 256. Asia Saliva Drug and Alcohol Testing Revenue by Application (2021-2026) & (US$ Million) Table 257. Asia Saliva Drug and Alcohol Testing Revenue by Application (2027-2032) & (US$ Million) Table 258. Asia Saliva Drug and Alcohol Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 259. Asia Saliva Drug and Alcohol Testing Revenue by Region (US$ Million) & (2021-2026) Table 260. Asia Saliva Drug and Alcohol Testing Revenue by Region (US$ Million) & (2027-2032) Table 261. SAMEA Saliva Drug and Alcohol Testing Revenue by Type (2021-2026) & (US$ Million) Table 262. SAMEA Saliva Drug and Alcohol Testing Revenue by Type (2027-2032) & (US$ Million) Table 263. SAMEA Saliva Drug and Alcohol Testing Revenue by Application (2021-2026) & (US$ Million) Table 264. SAMEA Saliva Drug and Alcohol Testing Revenue by Application (2027-2032) & (US$ Million) Table 265. SAMEA Saliva Drug and Alcohol Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 266. SAMEA Saliva Drug and Alcohol Testing Revenue by Country (2021-2026) & (US$ Million) Table 267. SAMEA Saliva Drug and Alcohol Testing Revenue by Country (US$ Million) & (2027-2032) Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Saliva Drug and Alcohol Testing Image Figure 2. Global Saliva Drug and Alcohol Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Saliva Drug and Alcohol Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-Site Screening Products Image Figure 5. Lab Testing Image Figure 6. Global Saliva Drug and Alcohol Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Saliva Drug and Alcohol Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Criminal Justice Testing Image Figure 9. Workplace Testing Image Figure 10. Rehabilitation Therapy Image Figure 11. Others Image Figure 12. Global Saliva Drug and Alcohol Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global Saliva Drug and Alcohol Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Saliva Drug and Alcohol Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Saliva Drug and Alcohol Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Saliva Drug and Alcohol Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Saliva Drug and Alcohol Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Saliva Drug and Alcohol Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Saliva Drug and Alcohol Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Saliva Drug and Alcohol Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Saliva Drug and Alcohol Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Saliva Drug and Alcohol Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032) Figure 25. North America Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032) Figure 26. North America Saliva Drug and Alcohol Testing Revenue Share by Country (2021-2032) Figure 27. United States Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Saliva Drug and Alcohol Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032) Figure 32. Europe Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032) Figure 33. Europe Saliva Drug and Alcohol Testing Revenue Share by Country (2021-2032) Figure 34. Germany Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Saliva Drug and Alcohol Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032) Figure 44. China Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032) Figure 45. Asia Saliva Drug and Alcohol Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032) Figure 47. Asia Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032) Figure 48. Asia Saliva Drug and Alcohol Testing Revenue Share by Region (2021-2032) Figure 49. Japan Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Saliva Drug and Alcohol Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA Saliva Drug and Alcohol Testing Revenue Share by Country (2021-2032) Figure 59. Brazil Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Saliva Drug and Alcohol Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • On-Site Screening Products
  • Lab Testing
Applications
  • Criminal Justice Testing
  • Workplace Testing
  • Rehabilitation Therapy
  • Others
Companies covered
  • Abbott
  • OraSure Technologies
  • Premier Biotech
  • Alcolizer
  • CareHealth America
  • AlphaBiolabs
  • AlcoDigital
  • VeriCheck
  • Azova
  • Draeger
  • Securetec Detektions-Systeme
  • Quest Diagnostics
  • Oranoxis
  • Salimetrics
  • Neogen Corporation
  • UCP Biosciences
  • Lin-Zhi International
  • MEDACX
  • AccuBioTech
  • Wondfo Biotech
  • Assure Tech
  • Express Medicals
  • Crystal Health
  • KINNECT
  • AusHealth
  • Dorevitch Pathology
  • Labcorp
  • Eurofins
  • Concentra
  • Bellin Health
  • Randox
  • MediNat
  • Clinical Labs
  • MHE
  • Awanui Labs
  • David Barber Occupational Health
  • SYNLAB
  • Test Smartly Labs
  • Cansford Laboratories
  • Medigold Health
  • PAM Group
  • Drugwise
  • Safework Health
  • Humanomics
  • CannAmm
  • Micro-Distributing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Saliva Drug and Alcohol Testing Market by Type
  3. 1.2.1 Global Saliva Drug and Alcohol Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-Site Screening Products
  5. 1.2.3 Lab Testing
  6. 1.3 Saliva Drug and Alcohol Testing Market by Application
  7. 1.3.1 Global Saliva Drug and Alcohol Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Criminal Justice Testing
  9. 1.3.3 Workplace Testing
  10. 1.3.4 Rehabilitation Therapy
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Saliva Drug and Alcohol Testing Market Dynamics
  1. 2.1 Saliva Drug and Alcohol Testing Industry Trends
  2. 2.2 Saliva Drug and Alcohol Testing Industry Drivers
  3. 2.3 Saliva Drug and Alcohol Testing Industry Opportunities and Challenges
  4. 2.4 Saliva Drug and Alcohol Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Saliva Drug and Alcohol Testing Market Perspective (2021-2032)
  2. 3.2 Global Saliva Drug and Alcohol Testing Growth Trends by Region
  3. 3.2.1 Global Saliva Drug and Alcohol Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Saliva Drug and Alcohol Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Saliva Drug and Alcohol Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Saliva Drug and Alcohol Testing Revenue by Players
  2. 4.1.1 Global Saliva Drug and Alcohol Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Saliva Drug and Alcohol Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Saliva Drug and Alcohol Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Saliva Drug and Alcohol Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Saliva Drug and Alcohol Testing Key Players Headquarters & Area Served
  7. 4.4 Global Saliva Drug and Alcohol Testing Players, Product Type & Application
  8. 4.5 Global Saliva Drug and Alcohol Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Saliva Drug and Alcohol Testing Market CR5 and HHI
  11. 4.6.3 2025 Saliva Drug and Alcohol Testing Tier 1, Tier 2, and Tier 3
5 Saliva Drug and Alcohol Testing Market Size by Type
  1. 5.1 Global Saliva Drug and Alcohol Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Saliva Drug and Alcohol Testing Revenue by Type (2021-2032)
  3. 5.3 Global Saliva Drug and Alcohol Testing Revenue Market Share by Type (2021-2032)
6 Saliva Drug and Alcohol Testing Market Size by Application
  1. 6.1 Global Saliva Drug and Alcohol Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Saliva Drug and Alcohol Testing Revenue by Application (2021-2032)
  3. 6.3 Global Saliva Drug and Alcohol Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Saliva Drug and Alcohol Testing Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 OraSure Technologies
  8. 7.2.1 OraSure Technologies Company Information
  9. 7.2.2 OraSure Technologies Business Overview
  10. 7.2.3 OraSure Technologies Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 OraSure Technologies Saliva Drug and Alcohol Testing Product Portfolio
  12. 7.2.5 OraSure Technologies Recent Developments
  13. 7.3 Premier Biotech
  14. 7.3.1 Premier Biotech Company Information
  15. 7.3.2 Premier Biotech Business Overview
  16. 7.3.3 Premier Biotech Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Premier Biotech Saliva Drug and Alcohol Testing Product Portfolio
  18. 7.3.5 Premier Biotech Recent Developments
  19. 7.4 Alcolizer
  20. 7.4.1 Alcolizer Company Information
  21. 7.4.2 Alcolizer Business Overview
  22. 7.4.3 Alcolizer Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Alcolizer Saliva Drug and Alcohol Testing Product Portfolio
  24. 7.4.5 Alcolizer Recent Developments
  25. 7.5 CareHealth America
  26. 7.5.1 CareHealth America Company Information
  27. 7.5.2 CareHealth America Business Overview
  28. 7.5.3 CareHealth America Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CareHealth America Saliva Drug and Alcohol Testing Product Portfolio
  30. 7.5.5 CareHealth America Recent Developments
  31. 7.6 AlphaBiolabs
  32. 7.6.1 AlphaBiolabs Company Information
  33. 7.6.2 AlphaBiolabs Business Overview
  34. 7.6.3 AlphaBiolabs Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AlphaBiolabs Saliva Drug and Alcohol Testing Product Portfolio
  36. 7.6.5 AlphaBiolabs Recent Developments
  37. 7.7 AlcoDigital
  38. 7.7.1 AlcoDigital Company Information
  39. 7.7.2 AlcoDigital Business Overview
  40. 7.7.3 AlcoDigital Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AlcoDigital Saliva Drug and Alcohol Testing Product Portfolio
  42. 7.7.5 AlcoDigital Recent Developments
  43. 7.8 VeriCheck
  44. 7.8.1 VeriCheck Company Information
  45. 7.8.2 VeriCheck Business Overview
  46. 7.8.3 VeriCheck Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 VeriCheck Saliva Drug and Alcohol Testing Product Portfolio
  48. 7.8.5 VeriCheck Recent Developments
  49. 7.9 Azova
  50. 7.9.1 Azova Company Information
  51. 7.9.2 Azova Business Overview
  52. 7.9.3 Azova Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Azova Saliva Drug and Alcohol Testing Product Portfolio
  54. 7.9.5 Azova Recent Developments
  55. 7.10 Draeger
  56. 7.10.1 Draeger Company Information
  57. 7.10.2 Draeger Business Overview
  58. 7.10.3 Draeger Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Draeger Saliva Drug and Alcohol Testing Product Portfolio
  60. 7.10.5 Draeger Recent Developments
  61. 7.11 Securetec Detektions-Systeme
  62. 7.11.1 Securetec Detektions-Systeme Company Information
  63. 7.11.2 Securetec Detektions-Systeme Business Overview
  64. 7.11.3 Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Product Portfolio
  66. 7.11.5 Securetec Detektions-Systeme Recent Developments
  67. 7.12 Quest Diagnostics
  68. 7.12.1 Quest Diagnostics Company Information
  69. 7.12.2 Quest Diagnostics Business Overview
  70. 7.12.3 Quest Diagnostics Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Quest Diagnostics Saliva Drug and Alcohol Testing Product Portfolio
  72. 7.12.5 Quest Diagnostics Recent Developments
  73. 7.13 Oranoxis
  74. 7.13.1 Oranoxis Company Information
  75. 7.13.2 Oranoxis Business Overview
  76. 7.13.3 Oranoxis Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Oranoxis Saliva Drug and Alcohol Testing Product Portfolio
  78. 7.13.5 Oranoxis Recent Developments
  79. 7.14 Salimetrics
  80. 7.14.1 Salimetrics Company Information
  81. 7.14.2 Salimetrics Business Overview
  82. 7.14.3 Salimetrics Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Salimetrics Saliva Drug and Alcohol Testing Product Portfolio
  84. 7.14.5 Salimetrics Recent Developments
  85. 7.15 Neogen Corporation
  86. 7.15.1 Neogen Corporation Company Information
  87. 7.15.2 Neogen Corporation Business Overview
  88. 7.15.3 Neogen Corporation Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Neogen Corporation Saliva Drug and Alcohol Testing Product Portfolio
  90. 7.15.5 Neogen Corporation Recent Developments
  91. 7.16 UCP Biosciences
  92. 7.16.1 UCP Biosciences Company Information
  93. 7.16.2 UCP Biosciences Business Overview
  94. 7.16.3 UCP Biosciences Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 UCP Biosciences Saliva Drug and Alcohol Testing Product Portfolio
  96. 7.16.5 UCP Biosciences Recent Developments
  97. 7.17 Lin-Zhi International
  98. 7.17.1 Lin-Zhi International Company Information
  99. 7.17.2 Lin-Zhi International Business Overview
  100. 7.17.3 Lin-Zhi International Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Lin-Zhi International Saliva Drug and Alcohol Testing Product Portfolio
  102. 7.17.5 Lin-Zhi International Recent Developments
  103. 7.18 MEDACX
  104. 7.18.1 MEDACX Company Information
  105. 7.18.2 MEDACX Business Overview
  106. 7.18.3 MEDACX Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 MEDACX Saliva Drug and Alcohol Testing Product Portfolio
  108. 7.18.5 MEDACX Recent Developments
  109. 7.19 AccuBioTech
  110. 7.19.1 AccuBioTech Company Information
  111. 7.19.2 AccuBioTech Business Overview
  112. 7.19.3 AccuBioTech Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 AccuBioTech Saliva Drug and Alcohol Testing Product Portfolio
  114. 7.19.5 AccuBioTech Recent Developments
  115. 7.20 Wondfo Biotech
  116. 7.20.1 Wondfo Biotech Company Information
  117. 7.20.2 Wondfo Biotech Business Overview
  118. 7.20.3 Wondfo Biotech Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Wondfo Biotech Saliva Drug and Alcohol Testing Product Portfolio
  120. 7.20.5 Wondfo Biotech Recent Developments
  121. 7.21 Assure Tech
  122. 7.21.1 Assure Tech Company Information
  123. 7.21.2 Assure Tech Business Overview
  124. 7.21.3 Assure Tech Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Assure Tech Saliva Drug and Alcohol Testing Product Portfolio
  126. 7.21.5 Assure Tech Recent Developments
  127. 7.22 Express Medicals
  128. 7.22.1 Express Medicals Company Information
  129. 7.22.2 Express Medicals Business Overview
  130. 7.22.3 Express Medicals Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Express Medicals Saliva Drug and Alcohol Testing Product Portfolio
  132. 7.22.5 Express Medicals Recent Developments
  133. 7.23 Crystal Health
  134. 7.23.1 Crystal Health Company Information
  135. 7.23.2 Crystal Health Business Overview
  136. 7.23.3 Crystal Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Crystal Health Saliva Drug and Alcohol Testing Product Portfolio
  138. 7.23.5 Crystal Health Recent Developments
  139. 7.24 KINNECT
  140. 7.24.1 KINNECT Company Information
  141. 7.24.2 KINNECT Business Overview
  142. 7.24.3 KINNECT Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  143. 7.24.4 KINNECT Saliva Drug and Alcohol Testing Product Portfolio
  144. 7.24.5 KINNECT Recent Developments
  145. 7.25 AusHealth
  146. 7.25.1 AusHealth Company Information
  147. 7.25.2 AusHealth Business Overview
  148. 7.25.3 AusHealth Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  149. 7.25.4 AusHealth Saliva Drug and Alcohol Testing Product Portfolio
  150. 7.25.5 AusHealth Recent Developments
  151. 7.26 Dorevitch Pathology
  152. 7.26.1 Dorevitch Pathology Company Information
  153. 7.26.2 Dorevitch Pathology Business Overview
  154. 7.26.3 Dorevitch Pathology Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Dorevitch Pathology Saliva Drug and Alcohol Testing Product Portfolio
  156. 7.26.5 Dorevitch Pathology Recent Developments
  157. 7.27 Labcorp
  158. 7.27.1 Labcorp Company Information
  159. 7.27.2 Labcorp Business Overview
  160. 7.27.3 Labcorp Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Labcorp Saliva Drug and Alcohol Testing Product Portfolio
  162. 7.27.5 Labcorp Recent Developments
  163. 7.28 Eurofins
  164. 7.28.1 Eurofins Company Information
  165. 7.28.2 Eurofins Business Overview
  166. 7.28.3 Eurofins Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Eurofins Saliva Drug and Alcohol Testing Product Portfolio
  168. 7.28.5 Eurofins Recent Developments
  169. 7.29 Concentra
  170. 7.29.1 Concentra Company Information
  171. 7.29.2 Concentra Business Overview
  172. 7.29.3 Concentra Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  173. 7.29.4 Concentra Saliva Drug and Alcohol Testing Product Portfolio
  174. 7.29.5 Concentra Recent Developments
  175. 7.30 Bellin Health
  176. 7.30.1 Bellin Health Company Information
  177. 7.30.2 Bellin Health Business Overview
  178. 7.30.3 Bellin Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Bellin Health Saliva Drug and Alcohol Testing Product Portfolio
  180. 7.30.5 Bellin Health Recent Developments
  181. 7.31 Randox
  182. 7.31.1 Randox Company Information
  183. 7.31.2 Randox Business Overview
  184. 7.31.3 Randox Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Randox Saliva Drug and Alcohol Testing Product Portfolio
  186. 7.31.5 Randox Recent Developments
  187. 7.32 MediNat
  188. 7.32.1 MediNat Company Information
  189. 7.32.2 MediNat Business Overview
  190. 7.32.3 MediNat Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  191. 7.32.4 MediNat Saliva Drug and Alcohol Testing Product Portfolio
  192. 7.32.5 MediNat Recent Developments
  193. 7.33 Clinical Labs
  194. 7.33.1 Clinical Labs Company Information
  195. 7.33.2 Clinical Labs Business Overview
  196. 7.33.3 Clinical Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  197. 7.33.4 Clinical Labs Saliva Drug and Alcohol Testing Product Portfolio
  198. 7.33.5 Clinical Labs Recent Developments
  199. 7.34 MHE
  200. 7.34.1 MHE Company Information
  201. 7.34.2 MHE Business Overview
  202. 7.34.3 MHE Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  203. 7.34.4 MHE Saliva Drug and Alcohol Testing Product Portfolio
  204. 7.34.5 MHE Recent Developments
  205. 7.35 Awanui Labs
  206. 7.35.1 Awanui Labs Company Information
  207. 7.35.2 Awanui Labs Business Overview
  208. 7.35.3 Awanui Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  209. 7.35.4 Awanui Labs Saliva Drug and Alcohol Testing Product Portfolio
  210. 7.35.5 Awanui Labs Recent Developments
  211. 7.36 David Barber Occupational Health
  212. 7.36.1 David Barber Occupational Health Company Information
  213. 7.36.2 David Barber Occupational Health Business Overview
  214. 7.36.3 David Barber Occupational Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  215. 7.36.4 David Barber Occupational Health Saliva Drug and Alcohol Testing Product Portfolio
  216. 7.36.5 David Barber Occupational Health Recent Developments
  217. 7.37 SYNLAB
  218. 7.37.1 SYNLAB Company Information
  219. 7.37.2 SYNLAB Business Overview
  220. 7.37.3 SYNLAB Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  221. 7.37.4 SYNLAB Saliva Drug and Alcohol Testing Product Portfolio
  222. 7.37.5 SYNLAB Recent Developments
  223. 7.38 Test Smartly Labs
  224. 7.38.1 Test Smartly Labs Company Information
  225. 7.38.2 Test Smartly Labs Business Overview
  226. 7.38.3 Test Smartly Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  227. 7.38.4 Test Smartly Labs Saliva Drug and Alcohol Testing Product Portfolio
  228. 7.38.5 Test Smartly Labs Recent Developments
  229. 7.39 Cansford Laboratories
  230. 7.39.1 Cansford Laboratories Company Information
  231. 7.39.2 Cansford Laboratories Business Overview
  232. 7.39.3 Cansford Laboratories Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  233. 7.39.4 Cansford Laboratories Saliva Drug and Alcohol Testing Product Portfolio
  234. 7.39.5 Cansford Laboratories Recent Developments
  235. 7.40 Medigold Health
  236. 7.40.1 Medigold Health Company Information
  237. 7.40.2 Medigold Health Business Overview
  238. 7.40.3 Medigold Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  239. 7.40.4 Medigold Health Saliva Drug and Alcohol Testing Product Portfolio
  240. 7.40.5 Medigold Health Recent Developments
  241. 7.41 PAM Group
  242. 7.42 Drugwise
  243. 7.43 Safework Health
  244. 7.44 Humanomics
  245. 7.45 CannAmm
  246. 7.46 Micro-Distributing
8 North America
  1. 8.1 North America Saliva Drug and Alcohol Testing Revenue (2021-2032)
  2. 8.2 North America Saliva Drug and Alcohol Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Saliva Drug and Alcohol Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Saliva Drug and Alcohol Testing Revenue by Type (2027-2032)
  5. 8.3 North America Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Saliva Drug and Alcohol Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Saliva Drug and Alcohol Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Saliva Drug and Alcohol Testing Revenue by Application (2027-2032)
  9. 8.5 North America Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Saliva Drug and Alcohol Testing Revenue by Country
  11. 8.6.1 North America Saliva Drug and Alcohol Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Saliva Drug and Alcohol Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Saliva Drug and Alcohol Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Saliva Drug and Alcohol Testing Revenue (2021-2032)
  2. 9.2 Europe Saliva Drug and Alcohol Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Saliva Drug and Alcohol Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Saliva Drug and Alcohol Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Saliva Drug and Alcohol Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Saliva Drug and Alcohol Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Saliva Drug and Alcohol Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Saliva Drug and Alcohol Testing Revenue by Country
  11. 9.6.1 Europe Saliva Drug and Alcohol Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Saliva Drug and Alcohol Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Saliva Drug and Alcohol Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Saliva Drug and Alcohol Testing Revenue (2021-2032)
  2. 10.2 China Saliva Drug and Alcohol Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Saliva Drug and Alcohol Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Saliva Drug and Alcohol Testing Revenue by Type (2027-2032)
  5. 10.3 China Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Saliva Drug and Alcohol Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Saliva Drug and Alcohol Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Saliva Drug and Alcohol Testing Revenue by Application (2027-2032)
  9. 10.5 China Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Saliva Drug and Alcohol Testing Revenue (2021-2032)
  2. 11.2 Asia Saliva Drug and Alcohol Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Saliva Drug and Alcohol Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Saliva Drug and Alcohol Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Saliva Drug and Alcohol Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Saliva Drug and Alcohol Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Saliva Drug and Alcohol Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Saliva Drug and Alcohol Testing Revenue by Country
  11. 11.6.1 Asia Saliva Drug and Alcohol Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Saliva Drug and Alcohol Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Saliva Drug and Alcohol Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Saliva Drug and Alcohol Testing Revenue (2021-2032)
  2. 12.2 SAMEA Saliva Drug and Alcohol Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Saliva Drug and Alcohol Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Saliva Drug and Alcohol Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Saliva Drug and Alcohol Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Saliva Drug and Alcohol Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Saliva Drug and Alcohol Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Saliva Drug and Alcohol Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Saliva Drug and Alcohol Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Saliva Drug and Alcohol Testing Revenue by Country
  11. 12.6.1 SAMEA Saliva Drug and Alcohol Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Saliva Drug and Alcohol Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Saliva Drug and Alcohol Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst